Portfolio company
Kerecis
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
This company develops fish skin tissue regeneration products for medical professionals to treat patients with chronic wounds, burns and surgical complications.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Omeza
This company develops marine-derived wound care products using fish peptides for healthcare providers treating patients with chronic or hard-to-heal skin ulcers.
CUTISS
This company develops bioengineered, personalised skin grafts for patients requiring surgery for severe burns or reconstructive procedures.
Fesarius Therapeutics
This company develops hydrogel dermal regeneration templates for surgeons and hospital systems to treat wounds and manage skin loss.
RedDress Medical
This company develops blood-based wound care systems for healthcare providers to treat patients with chronic, non-healing ulcers and tissue injuries.
Colzyx
This company develops bioactive collagen dressings and antimicrobial products for patients with chronic wounds, surgical injuries and bacterial infections.
DEBx Medical
This company develops chemical debridement agents for healthcare professionals to treat chronic wounds by removing infection and biofilm.
BioMimir
This company develops biomimetic polymers and resorbable wound fillers for healthcare providers to treat complex wounds and prevent scarring.
VERITACELL
This company produces surgical kits for point-of-care skin cell isolation and regeneration to help surgeons and hospitals treat patient wounds and scarring.
